Latest

    Genetic and Molecular Biomarkers

    Home Genetic and Molecular Biomarkers Page 4
    Explore the rapidly evolving world of genetic and molecular biomarkers through clear, evidence-based guides designed to make complex testing easier to understand. This main category brings together essential information on how DNA, chromosomes, genes, proteins, and other molecular signals are used to assess inherited disease risk, support diagnosis, guide treatment, monitor health, and inform family planning. Topics include genetic testing basics, inheritance patterns, carrier screening, predictive and diagnostic testing, variant classification, and advanced sequencing methods such as multigene panels, whole-exome sequencing, and whole-genome sequencing. Detailed condition-specific guides cover inherited disorders, cardiovascular and metabolic diseases, neurologic and psychiatric conditions, reproductive and prenatal genetics, newborn screening, HLA and immune testing, and hereditary cancer syndromes. The collection also explains pharmacogenetic testing for medication response, toxicity risk, and dose selection, including tests related to antidepressants, pain medicines, anticoagulants, chemotherapy, transplant drugs, and severe drug reactions. Molecular testing methods such as PCR, next-generation sequencing, chromosomal microarray, FISH, liquid biopsy, RNA sequencing, methylation analysis, and copy-number testing are presented in practical clinical context. Cancer genetics and molecular tumor testing are covered extensively, including hereditary cancer panels, tumor mutations, gene fusions, circulating tumor DNA, comprehensive genomic profiling, targeted therapy biomarkers, immunotherapy markers, minimal residual disease, and treatment-resistance testing. Each guide explains why a test may be ordered, what sample is needed, how results are interpreted, important limitations, potential follow-up, and when genetic counseling or specialist care may be helpful.
    Compare prenatal genetic screening with CVS and amniocentesis, understand cell-free DNA and diagnostic results, and learn how timing, test scope, false positives, and follow-up affect care.

    Prenatal Genetic Testing: Screening, Diagnosis, Risk, and Results

    Understand presymptomatic genetic testing, who may consider it, how positive and negative results affect inherited disease risk, and what happens next.

    Presymptomatic Genetic Testing: Inherited Disease Risk and Results

    Learn how single-gene genetic tests work, what pathogenic, negative, and VUS results mean, how they affect disease risk, and why test method matters.

    Single-Gene Genetic Test: Mutation Results, Disease Risk, and Meaning

    Learn how somatic genetic testing finds tumor mutations, guides cancer treatment, uses tissue or liquid biopsy, and distinguishes actionable from uncertain results.

    Somatic Genetic Testing: Tumor Mutations, Cancer Treatment, and Results

    Understand tumor genomic testing, how cancer mutations are matched to targeted therapy, what result categories mean, and why an actionable target may not work.

    Tumor Genomic Testing: Cancer Mutations, Targeted Therapy, and Results

    Learn what a variant of uncertain significance means, why VUS results occur, what they should not change, how reclassification works, and what to ask next.

    Variant of Uncertain Significance (VUS): Genetic Test Results and Meaning

    Understand whole-exome sequencing, who may benefit, how trio analysis works, what positive and negative results mean, and why reanalysis can find answers later.

    Whole-Exome Sequencing (WES) Test: Genetic Diagnosis, Variants, and Results

    Understand what whole-genome sequencing tests, what positive, negative, and uncertain WGS results mean, its limitations, disease-risk findings, privacy issues, and next steps.

    Whole-Genome Sequencing (WGS) Test: DNA Variants, Disease Risk, and Results

    Learn how X-linked genetic tests identify variants, how inheritance and carrier risk work, what positive, negative, and VUS results mean, and which follow-up steps matter.

    X-Linked Genetic Test: Inheritance Pattern, Carrier Risk, and Results

    Learn how SERPINA1 genetic testing, AAT blood levels, and protein phenotyping diagnose alpha-1 antitrypsin deficiency and guide lung, liver, and family follow-up.

    Alpha-1 Antitrypsin Deficiency Genetic Test: SERPINA1, Liver, Lung, and Results

    Understand how APOB genetic testing can identify LDL-raising familial hypercholesterolemia or LDL-lowering hypobetalipoproteinemia and how results guide treatment and family screening.

    APOB Genetic Test: High LDL Cholesterol, Heart Risk, and Results

    Understand APOE ε2, ε3, and ε4 genotype results for cholesterol, late-onset Alzheimer susceptibility, and ARIA risk before anti-amyloid treatment.

    APOE Genotype Test: Cholesterol, Alzheimer Disease Risk, and Results

    Learn how PKP2, DSP, DSG2, and other arrhythmogenic cardiomyopathy genetic results are interpreted and used for diagnosis, exercise counseling, treatment, and family screening.

    Arrhythmogenic Cardiomyopathy Genetic Test: PKP2, DSP, DSG2, and Results

    Learn how the SCN5A genetic test supports Brugada syndrome diagnosis, what positive, negative, and uncertain results mean, and how findings guide fever precautions, treatment, and family screening.

    Brugada Syndrome Genetic Test: SCN5A Gene, Heart Rhythm Risk, and Results

    Understand what a cardiovascular genetic panel tests, who may benefit, how pathogenic and uncertain results are interpreted, and how findings can guide care and family screening.

    Cardiovascular Genetic Panel Test: Heart Disease Genes, Risk, and Results

    Learn how RYR2 genetic testing supports CPVT diagnosis, what positive, negative, and uncertain results mean, and how findings guide treatment, exercise safety, and family screening.

    Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Genetic Test: RYR2 and Results

    Learn how TTN, LMNA, and MYH7 genetic testing supports dilated cardiomyopathy diagnosis, how results influence rhythm and heart-failure care, and how families are screened.

    Dilated Cardiomyopathy Genetic Test: TTN, LMNA, MYH7, and Results

    Learn what the Factor V Leiden genetic test detects, how heterozygous and homozygous results affect venous clot risk, and when findings may influence treatment, pregnancy, estrogen, surgery, and family testing.

    Factor V Leiden Genetic Test: Blood Clot Risk, Mutation, and Results

    Learn when familial and early-onset atrial fibrillation genetic testing may help, how results can reveal cardiomyopathy risk, and why stroke prevention and rhythm treatment remain clinically based.

    Familial Atrial Fibrillation Genetic Test: Heart Rhythm Risk and Results

    Learn how LDLR, APOB, and PCSK9 genetic testing supports familial hypercholesterolemia diagnosis, what results mean, and how findings guide treatment and cascade screening in adults and children.

    Familial Hypercholesterolemia Genetic Test: LDLR, APOB, PCSK9, and Results

    1...345...9Page 4 of 9
    © Vita Library 2026